129 related articles for article (PubMed ID: 28866246)
21. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
22. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
24. Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study.
Hong B; Zhang Z; Zhou J; Ma K; Zhang J; Cai L; Zhang N; Gong K
Oncol Lett; 2019 May; 17(5):4600-4606. PubMed ID: 30944649
[TBL] [Abstract][Full Text] [Related]
25. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
27. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
28. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
29. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
[TBL] [Abstract][Full Text] [Related]
30. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.
Kwon T; Jeong IG; Pak S; You D; Song C; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1171-7. PubMed ID: 24671227
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
32. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
del Cura JL; Zabala R; Iriarte JI; Unda M
Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
[TBL] [Abstract][Full Text] [Related]
33. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States.
Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
Clin Genitourin Cancer; 2023 Apr; 21(2):238-247. PubMed ID: 36682891
[TBL] [Abstract][Full Text] [Related]
35. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
36. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
[TBL] [Abstract][Full Text] [Related]
37. Sorafenib treatment for recurrent stage T1 bilateral renal cell carcinoma in patients with Von Hippel- Lindau disease: A case report and literature review.
Choi KH; Yu YD; Kang MH; Park DS
Can Urol Assoc J; 2015; 9(9-10):E651-3. PubMed ID: 26425233
[TBL] [Abstract][Full Text] [Related]
38. Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.
Wah TM; Sourbron S; Wilson DJ; Magee D; Gregory WM; Selby PJ; Buckley DL
Diagnostics (Basel); 2018 Jan; 8(1):. PubMed ID: 29316711
[TBL] [Abstract][Full Text] [Related]
39. Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers.
Iacovelli R; Arduini D; Ciccarese C; Pierconti F; Strusi A; Piro G; Carbone C; Foschi N; Daniele G; Tortora G
Crit Rev Oncol Hematol; 2022 Aug; 176():103750. PubMed ID: 35728738
[TBL] [Abstract][Full Text] [Related]
40. Renal cell carcinoma in children and young adults: clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up.
Rao Q; Chen JY; Wang JD; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Int J Surg Pathol; 2011 Apr; 19(2):170-9. PubMed ID: 20034980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
